PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy — PRAHA

Ovarian Cyst Benign Clinical Trial

Official title:
A Single Center, Randomized, Investigator-initiated Phase III Trial to Evaluate the Efficacy of Preservation of Ovarian Function and Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy

Status Completed

Clinical Trial Summary

The purpose of this study is to compare hemostasis, ovarian function preservation effect, and safety about intraoperative bleeding with SurgiGuard@ in women who underwent laparoscopic unilateral ovarian cystectomy

Clinical Trial Description

In women who underwent laparoscopic unilateral ovarian cystectomy, the effect of SurgiGuard@ was assessed by randomization, using SurgiGuard@ and Bipolar electro cauterization, followed by comparative evaluation of hemostasis, ovarian function preservation, safety using postoperative Hb, anti-mullerian hormone (AMH), pelvis ultrasonography (USG), and physical examination ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03374397
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	December 6, 2017
Completion date	August 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05514028` - Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
Not yet recruiting	`NCT04788498` - Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy	N/A
Recruiting	`NCT04224467` - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery	N/A
Recruiting	`NCT06350227` - Impact of Different Hemostasis Methods on Ovarian Function and Fertility During Laparoscopic Ovarian Cystectomy of Benign Ovarian Cyst	N/A